The Centers for Disease Control and Prevention yesterday released an operational planning guide for pediatric COVID-19 vaccination and preliminary information on the pediatric Pfizer COVID-19 vaccine. The Food and Drug Administration is considering whether to authorize emergency use of the Pfizer vaccine for children aged 5-11, with a decision expected in the coming weeks. The new planning documents expand on an initial CDC document released this week on packaging changes and storage requirements for the Pfizer pediatric COVID-19 vaccine for children ages 5-11. The new planning guide includes additional information about the rollout of the pediatric vaccine; projected launch plan considerations for jurisdictions; and a readiness checklist for supply and ordering, provider network adequacy, information technology systems for reporting and monitoring, and communications.

Related News Articles

Headline
In a study of symptomatic adults tested for SARS-CoV-2 at U.S. pharmacies since Sept. 14, bivalent COVID-19 vaccine boosters provided additional protection…
Headline
The Biden Administration today launched a six-week campaign to encourage Americans to get an updated COVID-19 vaccine. In addition to ongoing pop-up clinics,…
Headline
Children under age 5 are more likely to receive a COVID-19 vaccine if their parents perceive it as safe and their health care provider recommends it, according…
Headline
AHA this week released a new Thanksgiving-focused toolkit to help promote pediatric COVID-19 vaccination on social media, including sample content and graphics…
Headline
The Food and Drug Administration recently updated its health care provider fact sheet on bebtelovimab to note that the monoclonal antibody is not expected…
Headline
Black patients who sought outpatient care for COVID-19 between January and July 2022 were 36% less likely than white patients to receive the antiviral pill…